Clinical Trial Update: Diacerin for the Treatment of Epidermolysis Bullosa Simplex [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating Diacerin for Epidermolysis Bullosa Simplex, with the current trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa Simplex

Drugs mentioned

• Diacerin

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Epidermolysis Bullosa Simplex | Phase 2 | Status: UNKNOWN